Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Development of a multimarker assay for early detection of ovarian cancer.

Publication ,  Journal Article
Yurkovetsky, Z; Skates, S; Lomakin, A; Nolen, B; Pulsipher, T; Modugno, F; Marks, J; Godwin, A; Gorelik, E; Jacobs, I; Menon, U; Lu, K ...
Published in: J Clin Oncol
May 1, 2010

PURPOSE: Early detection of ovarian cancer has great promise to improve clinical outcome. PATIENTS AND METHODS: Ninety-six serum biomarkers were analyzed in sera from healthy women and from patients with ovarian cancer, benign pelvic tumors, and breast, colorectal, and lung cancers, using multiplex xMAP bead-based immunoassays. A Metropolis algorithm with Monte Carlo simulation (MMC) was used for analysis of the data. RESULTS: A training set, including sera from 139 patients with early-stage ovarian cancer, 149 patients with late-stage ovarian cancer, and 1,102 healthy women, was analyzed with MMC algorithm and cross validation to identify an optimal biomarker panel discriminating early-stage cancer from healthy controls. The four-biomarker panel providing the highest diagnostic power of 86% sensitivity (SN) for early-stage and 93% SN for late-stage ovarian cancer at 98% specificity (SP) was comprised of CA-125, HE4, CEA, and VCAM-1. This model was applied to an independent blinded validation set consisting of sera from 44 patients with early-stage ovarian cancer, 124 patients with late-stage ovarian cancer, and 929 healthy women, providing unbiased estimates of 86% SN for stage I and II and 95% SN for stage III and IV disease at 98% SP. This panel was selective for ovarian cancer showing SN of 33% for benign pelvic disease, SN of 6% for breast cancer, SN of 0% for colorectal cancer, and SN of 36% for lung cancer. CONCLUSION: A panel of CA-125, HE4, CEA, and VCAM-1, after additional validation, could serve as an initial stage in a screening strategy for epithelial ovarian cancer.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

May 1, 2010

Volume

28

Issue

13

Start / End Page

2159 / 2166

Location

United States

Related Subject Headings

  • beta-Defensins
  • Vascular Cell Adhesion Molecule-1
  • Sensitivity and Specificity
  • Reproducibility of Results
  • Prognosis
  • Predictive Value of Tests
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Monte Carlo Method
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yurkovetsky, Z., Skates, S., Lomakin, A., Nolen, B., Pulsipher, T., Modugno, F., … Lokshin, A. E. (2010). Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol, 28(13), 2159–2166. https://doi.org/10.1200/JCO.2008.19.2484
Yurkovetsky, Zoya, Steven Skates, Aleksey Lomakin, Brian Nolen, Trenton Pulsipher, Francesmary Modugno, Jeffrey Marks, et al. “Development of a multimarker assay for early detection of ovarian cancer.J Clin Oncol 28, no. 13 (May 1, 2010): 2159–66. https://doi.org/10.1200/JCO.2008.19.2484.
Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, et al. Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol. 2010 May 1;28(13):2159–66.
Yurkovetsky, Zoya, et al. “Development of a multimarker assay for early detection of ovarian cancer.J Clin Oncol, vol. 28, no. 13, May 2010, pp. 2159–66. Pubmed, doi:10.1200/JCO.2008.19.2484.
Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, Marks J, Godwin A, Gorelik E, Jacobs I, Menon U, Lu K, Badgwell D, Bast RC, Lokshin AE. Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol. 2010 May 1;28(13):2159–2166.

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

May 1, 2010

Volume

28

Issue

13

Start / End Page

2159 / 2166

Location

United States

Related Subject Headings

  • beta-Defensins
  • Vascular Cell Adhesion Molecule-1
  • Sensitivity and Specificity
  • Reproducibility of Results
  • Prognosis
  • Predictive Value of Tests
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Monte Carlo Method